Company Filing History:
Years Active: 2012-2015
Title: Regent Laporte: Innovator in Medicinal Chemistry
Introduction
Regent Laporte is a notable inventor based in San Diego, CA (US). He has made significant contributions to the field of medicinal chemistry, holding a total of 4 patents. His work primarily focuses on the development of novel compounds for medical applications.
Latest Patents
Regent Laporte's latest patents include innovative uses of peptidic vasopressin receptor agonists. The first patent relates to the use of these compounds for the manufacture of a medicament aimed at treating conditions associated with critical care. The compounds are represented by a specific general formula, as detailed in the patent specification. The second patent also involves peptidic vasopressin receptor agonists, focusing on their use in pharmaceutical compositions for treating shock conditions. Similar to the first, these compounds are defined by a general formula outlined in the specification.
Career Highlights
Regent Laporte is currently associated with Ferring B.V., a company known for its commitment to advancing healthcare through innovative solutions. His work at Ferring B.V. has allowed him to explore and develop groundbreaking medicinal compounds that address critical health issues.
Collaborations
Throughout his career, Regent has collaborated with esteemed colleagues such as Kazimierz Wisniewski and Claudio Daniel Schteingart. These collaborations have further enriched his research and development efforts in the field of medicinal chemistry.
Conclusion
Regent Laporte's contributions to medicinal chemistry through his patents and collaborations highlight his role as an innovator in the field. His work continues to pave the way for advancements in medical treatments.